Synergistic effects of cholesteryl ester transfer protein, apolipoprotein E, and apolipoprotein C3 gene polymorphisms on coronary artery disease risk

被引：0
|
作者：
Muendlein, A.
Saely, C. H.
Aczel, S.
Marte, T.
Schmid, F.
Koch, L.
Rein, P.
Langer, P.
Drexel, H.
机构：
[1] VIVIT Inst, Feldkich, Austria
[2] Acad Teaching Hosp, Feldkich, Austria
[3] Univ Human Sci, Triesen, Liechtenstein
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)71815-9
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [31] Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease
    Wen Dai
    Ziyu Zhang
    Chun Yao
    Shuiping Zhao
    Lipids in Health and Disease, 18
  • [32] Cholesterol ester transfer protein and apolipoprotein E gene polymorphisms in hyperlipidemic Asian Indians in North India
    Meena, Kiran
    Misra, Anoop
    Vikram, Naval
    Ali, Shakir
    Pandey, R. M.
    Luthra, Kalpana
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 352 (1-2) : 189 - 196
  • [33] Polymorphisms in the apolipoprotein E gene regulatory region in relation to coronary heart disease and their effect on plasma apolipoprotein E
    Corbo, RM
    Scacchi, R
    Vilardo, T
    Ruggeri, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (01) : 2 - 6
  • [34] Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting
    Koch, W
    Mehilli, J
    Pfeufer, A
    Schömig, A
    Kastrati, A
    JOURNAL OF LIPID RESEARCH, 2004, 45 (12) : 2221 - 2226
  • [35] Marked elevation in serum apolipoprotein E in a case of heterozygous cholesteryl ester transfer protein deficiency
    Hirayama, S
    Kobayashi, J
    Taira, K
    Hikita, M
    Bujo, H
    Morisaki, N
    Matsunaga, A
    Sasaki, J
    Saito, Y
    CLINICA CHIMICA ACTA, 2000, 301 (1-2) : 55 - 64
  • [36] Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease
    Bennouar, N
    Allami, A
    Laraqui, A
    Azeddoug, H
    El Kadiri, N
    Benkouka, F
    Bendriss, A
    Ghannam, R
    Benomar, A
    Fellat, S
    Benomar, M
    ANNALES DE BIOLOGIE CLINIQUE, 2004, 62 (03) : 295 - 304
  • [37] Apolipoprotein A1 gene polymorphisms and risk of early coronary disease
    Reguero, JR
    Cubero, GI
    Batalla, A
    Alvarez, V
    Hevia, S
    Cortina, A
    Coto, E
    CARDIOLOGY, 1998, 90 (03) : 231 - 235
  • [38] Apolipoprotein C3 Gene Polymorphism in Nonalcoholic Fatty Liver Disease-To Be or Not To Be Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
    Petersen, K. F.
    Dufour, S.
    Hariri, A.
    Nelson-Williams, C.
    Foo, J. N.
    Zhang, X. M.
    Dziura, J.
    Lifton, R. P.
    Shulman, G., I
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2011, 1 (01) : 51 - 52
  • [39] Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism
    Brousseau, Margaret E.
    Millar, John S.
    Diffenderfer, Margaret R.
    Nartsupha, Chorthip
    Asztalos, Bela F.
    Wolfe, Megan L.
    Mancuso, James P.
    Digenio, Andres G.
    Rader, Daniel J.
    Schaefer, Ernst J.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (07) : 1456 - 1462
  • [40] Dissecting the Association of Apolipoprotein E Gene Polymorphisms With Type 2 Diabetes Mellitus and Coronary Artery Disease
    Wu, Lei
    Zhang, Yan
    Zhao, Hong
    Rong, Guodong
    Huang, Peijun
    Wang, Fang
    Xu, Ting
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
12345